Boston Scientific Corp. | Balance Sheet

Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
217
587
319
439
991
801
Total Accounts Receivable
1,307
1,183
1,275
1,472
1,548
1,608
Inventories
897
946
1,016
955
1,078
1,166
Other Current Assets
590
890
861
373
205
427
Total Current Assets
3,011
3,606
3,471
3,239
3,822
4,002
Net Property, Plant & Equipment
1,546
1,507
1,490
1,630
1,697
1,782
Total Investments and Advances
-
-
-
-
305
397
Long-Term Note Receivable
-
-
-
-
47
26
Intangible Assets
11,643
11,504
12,667
12,561
12,835
14,283
Other Assets
329
368
465
586
248
422
Total Assets
16,571
17,024
18,133
18,096
19,042
20,999
ST Debt & Current Portion LT Debt
3
403
3
64
1,801
Accounts Payable
246
262
209
447
530
Income Tax Payable
2
2
2
-
-
Other Current Liabilities
1,573
2,179
2,216
3,076
3,323
Total Current Liabilities
1,824
2,846
2,430
3,587
5,654
Long-Term Debt
4,237
3,841
5,674
5,420
3,815
Provision for Risks & Charges
876
999
1,290
1,102
569
Deferred Taxes
1,360
1,175
695
62
103
Other Liabilities
1,693
1,667
1,684
1,236
1,801
Total Liabilities
10,032
10,567
11,813
11,363
12,030
Common Equity (Total)
6,539
6,457
6,320
6,733
7,012
Total Shareholders' Equity
6,539
6,457
6,320
6,733
7,012
Total Equity
6,539
6,457
6,320
6,733
7,012
Liabilities & Shareholders' Equity
16,571
17,024
18,133
18,096
19,042

About Boston Scientific

View Profile
Address
300 Boston Scientific Way
Marlborough Massachusetts 01752
United States
Employees -
Website http://www.bostonscientific.com
Updated 07/08/2019
Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. It operates through the following segments: Cardiovascular, Rhythm Management, and MedSurg. The Cardiovascular segment comprises of technologies or diagnosing and treating coronary artery disease, and other cardiovascular disorders including structural heart conditions.